| For: | Tang YL, Li DD, Duan JY, Sheng LM, Wang X. Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments. World J Gastroenterol 2023; 29(6): 926-948 [PMID: 36844139 DOI: 10.3748/wjg.v29.i6.926] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i6/926.htm |
| Number | Citing Articles |
| 1 |
RamaRao Malla, Anuveda Sree Samudrala, Yerusha Nuthalapati, Priyamvada Bhamidipati, Ganji Purnachandra Nagaraju. Targeting DNA Repair Mechanisms, Tumor Genetics, and Signaling Pathways. 2026; doi: 10.1016/B978-0-443-43976-6.00018-1
|
| 2 |
Na Lu, Xiao Guan, Jianguo Zhu, Yuan Li, Jianping Zhang. A Contrast-Enhanced CT-Based Deep Learning System for Preoperative Prediction of Colorectal Cancer Staging and RAS Mutation. Cancers 2023; 15(18) doi: 10.3390/cancers15184497
|
| 3 |
Molly McKenzie, Guang-Yu Lian, Kathryn A.F. Pennel, Jean A. Quinn, Nigel B. Jamieson, Joanne Edwards. NFκB signalling in colorectal cancer: Examining the central dogma of IKKα and IKKβ signalling. Heliyon 2024; 10(12) doi: 10.1016/j.heliyon.2024.e32904
|
| 4 |
Mehran Molavand, Maryam Majidinia, Bahman Yousefi. Critical Contribution of Various Signaling Pathways in the Development of Drug Resistance in Colorectal Cancer: An Update. IUBMB Life 2025; 77(11) doi: 10.1002/iub.70074
|
| 5 |
Kelin Yue, Haolin Wu, Kexin Li, Shu Yang, Xuan Bai, Wenjing Zhang, Yu Zhang. HSF4 alleviates ferroptosis in colorectal cancer through transcriptional regulation of MBOAT1/2. Functional & Integrative Genomics 2026; 26(1) doi: 10.1007/s10142-026-01822-2
|
| 6 |
Deli-Bright N.T. Oku, Damilare D. Babatunde, Yannick Nuapia, Garland K. More, Ramakwala Christinah Chokwe. Harnessing Machine Learning for the Virtual Screening of Natural Compounds as Both EGFR and HER2 Inhibitors in Colorectal Cancer: A Novel Therapeutic Approach. ACS Omega 2025; 10(47) doi: 10.1021/acsomega.5c07683
|
| 7 |
Kuen-Tze Lin, Yu-Chieh Hsieh, Pi-Kai Chang, Chih-Wei Lai, Shih-Yu Lee, I-Chuan Yen. 4‑Acetylantrocamol LT3 suppresses colorectal cancer growth and metastasis via PI3K/AKT and MAPK pathway modulation. International Journal of Molecular Medicine 2026; 57(5) doi: 10.3892/ijmm.2026.5797
|
| 8 |
Chengzu Wang. Mapping the Future: A Comprehensive Bibliometric Analysis of Circulating Tumor DNA in Colorectal Cancer. Journal of Multidisciplinary Healthcare 2024; doi: 10.2147/JMDH.S493863
|
| 9 |
Amina T. Mneimneh, Nadine Darwiche, Mohammed M. Mehanna. Investigating the therapeutic promise of drug-repurposed-loaded nanocarriers: A pioneering strategy in advancing colorectal cancer treatment. International Journal of Pharmaceutics 2024; 664 doi: 10.1016/j.ijpharm.2024.124473
|
| 10 |
Patricia Garcia Pastor, Nadia Saoudi González, Francesc Salva, Javier Ros, Iosune Baraibar, Marta Rodríguez Castells, Clara Salva de Torres, Ariadna García, Adriana Alcaraz, Caterina Vaghi, Josep Tabernero, Elena Elez. Genomic Landscape, Targeted Therapies, and Mechanisms of Resistance in Molecularly Selected Metastatic Colorectal Cancer Patients. Genes 2026; 17(4) doi: 10.3390/genes17040460
|
| 11 |
Yuanyuan Liang, Xiangyun Li, Hui Liang, Tao Wu, Yao Huang, Shoumei Liu, Xia Yang, Rui Luo, Fanxin Ma, Ying Huang, Xiaoan Li, Yan Zhou. Preclinical Evaluation of 5T4-Targeted [89Zr]Zr-DFO-HB5 Immuno-PET Imaging and Comparison of 161Tb vs 177Lu Radionuclide Therapy for Colorectal Cancer. Journal of Medicinal Chemistry 2026; 69(9) doi: 10.1021/acs.jmedchem.5c03745
|
| 12 |
Nikolett Szakállas, Alexandra Kalmár, Barbara Kinga Barták, Zsófia Brigitta Nagy, Gábor Valcz, Tamás Richárd Linkner, Kristóf Róbert Rada, István Takács, Béla Molnár. Investigation of Exome-Wide Tumor Heterogeneity on Colorectal Tissue-Based Single Cells. International Journal of Molecular Sciences 2025; 26(2) doi: 10.3390/ijms26020737
|
| 13 |
Mahmoud Singer, Jennifer Valerin, Zhuoli Zhang, Zigeng Zhang, Farshid Dayyani, Vahid Yaghmai, April Choi, David Imagawa, Nadine Abi-Jaoudeh. Promising Cellular Immunotherapy for Colorectal Cancer Using Classical Dendritic Cells and Natural Killer T Cells. Cells 2025; 14(3) doi: 10.3390/cells14030166
|
| 14 |
Anggraeni E. Kusumaningrum, Sarce Makaba, Eyhab Ali, Mandeep Singh, Mohammed N. Fenjan, Irodakhon Rasulova, Neeti Misra, Sada G. Al‐ Musawi, Ali Alsalamy. A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance. Cell Biochemistry and Function 2024; 42(1) doi: 10.1002/cbf.3906
|
| 15 |
Fei-Yan Zhou, Bo-Hong Xu, Yue Du, Han Yu, Fang-Hua Song. Integrating network pharmacology, molecular docking, and experimental validation, this study explores the mechanism of action of Typhonii Rhizoma in colon cancer. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1815506
|
| 16 |
Hawraa Ibrahim Alshakarchi, Hanieh Azari, Zuhair Mohammed Ali Jeddoa, Nadhir N.A. Jafar, Yeganeh Khazaei, Ibrahim Saeed Gataa, Gordon A. Ferns, Amir Avan. Metabolic Targets in CRC: The Emerging Role of Cytochrome P450 Inhibitors. Current Pharmaceutical Design 2025; 31(42) doi: 10.2174/0113816128341167250520063502
|
| 17 |
Mohammad Kordkatouli, Mahmoud Heidari, Nasrinsadat Azami, Javad Poursamimi. Colorectal Cancer Pathogenesis and Treatment Strategies: Insights into the Role of p53. Multidisciplinary Cancer Investigation 2025; 8(2) doi: 10.61882/mci.8.2.1
|
| 18 |
Hongyuan Wu, Heling Dong, Shaofang Ren, Jianxin Chen, Yan Zhang, Meng Dai, Yinfen Wu, Xuefang Zhang. Exploration of novel clusters and prognostic value of immune‑related signatures and identify HAMP as hub gene in colorectal cancer. Oncology Letters 2023; 26(2) doi: 10.3892/ol.2023.13946
|
| 19 |
Jianping Wang, Jun An, Lixuan Tian, Yuzi Jin, Yalei Li, Peijian Ding, Wenjing Yun, Yunpeng Zhang, Shuang Zhao. KW2478 and Cisplatin Synergistically Anti-colorectal Cancer by Targeting PI3K/AKT/mTOR Pathway. Anti-Cancer Agents in Medicinal Chemistry 2025; 25(11) doi: 10.2174/0118715206356311241128075924
|
| 20 |
Karen Bartley, Jeremy Snider, Cheryl Cho-Phan, Jingru Wang, Peter Martin, Cyndy Simon, Edward Neuberger, Naureen Starling. The prognostic impact of human epidermal growth factor receptor 2 status in metastatic colorectal cancer. Future Science OA 2025; 11(1) doi: 10.1080/20565623.2025.2527482
|
| 21 |
Jun-Fei Lu, Xin-Ran Zhang, Ye Liu, Chang-Li Zhang, Li Wang, Zhi-Qiang Liu, Jun Cai, Hua-Wei Yi. Innovative Applications of Nucleic Acid Aptamers in Colorectal Cancer Diagnosis and Therapy: From Selection Optimization to Clinical Translation. International Journal of Nanomedicine 2025; doi: 10.2147/IJN.S547463
|
| 22 |
Lloyd Mabonga, Rebecca Leony Fourie, Abidemi Paul Kappo, Sylvester Lyantagaye, Zodwa Dlamini. Colorectal Cancer Treatment Resistance. 2025; doi: 10.1016/B978-0-443-33475-7.00001-9
|
| 23 |
Rachana Choudhary, Neetu Das, Bhuneshwari Nayak, Rachana Tiwari, Ananya Malekar, Vaibhavi Sahare. Advancements in Drug Discovery Techniques for Cancer Treatment: Clinical Progress and Future Directions. Current Drug Discovery Technologies 2026; 23(2) doi: 10.2174/0115701638365059250707070424
|
| 24 |
Ali Gholamian Moghaddam, Atchimnaidu Siriki, Debajyoti Majumder, Heba E. Elsayed, Hassan Y. Ebrahim, Khalid El Sayed, Siva Murru. Pyrazolone Compounds as Promising Anticancer Agents for Colorectal Cancer: Synthesis, Antiproliferative Activity, and Mechanistic Insights. ChemMedChem 2026; 21(7) doi: 10.1002/cmdc.202500864
|
| 25 |
Shanshan Zhang, Ying Wei, Tingting Liu, Chenhao Sun, Xiuzhen Ge, Yang Ni, Xiaonan Tang, Mridul Roy, Tingmin Chang, Xiaohong Kang. Rap2B-mediated reprogramming of the PI3K/AKT signaling axis drives resistance to cetuximab-targeted therapy in colorectal carcinoma. Biological Procedures Online 2025; 27(1) doi: 10.1186/s12575-025-00303-3
|
| 26 |
Yan-Dong Miao, Hao Lin, Wen-Yu Luan. Recommendations for articles and reviews in colorectal cancer-related research at the year-end of 2023. World Journal of Gastroenterology 2024; 30(30): 3548-3553 doi: 10.3748/wjg.v30.i30.3548
|
| 27 |
Ziwei Wang, Yasai Sun, Mengying Wu, Liangfu Zhou, Yu Zheng, Ting Ren, Meijiao Li, Wen Zhao. Hawthorn Proanthocyanidin Extract Inhibits Colorectal Carcinoma Metastasis by Targeting the Epithelial-Mesenchymal Transition Process and Wnt/β-Catenin Signaling Pathway. Foods 2024; 13(8) doi: 10.3390/foods13081171
|
| 28 |
Dipa K. Israni, Jignesh Shah, Mansi Shah, Heena Chauhan, Bhupendra G. Prajapati, Yunqi Zhao, Chuda Chittasupho, Sudarshan Singh. Emerging Molecular Insights and Targeted Therapeutics in Colorectal Cancer: From Emerging Approaches to Personalized Medicine. Journal of Gastrointestinal Cancer 2026; 57(1) doi: 10.1007/s12029-026-01447-5
|
| 29 |
Hiba Fadlallah, Jad El Masri, Hiam Fakhereddine, Joe Youssef, Chrystelle Chemaly, Samer Doughan, Wassim Abou-Kheir. Colorectal cancer: Recent advances in management and treatment. World Journal of Clinical Oncology 2024; 15(9): 1136-1156 doi: 10.5306/wjco.v15.i9.1136
|
| 30 |
Mingtang Zeng, Yao Wang, Xuelin Tao, Tianfei Fan, Xi Yin, Chao Shen, Xueyan Wang. Novel Perspectives in the Management of Colorectal Cancer: Mechanistic Investigations Into the Reversal of Drug Resistance via Active Constituents Derived From Herbal Medicine. Phytotherapy Research 2024; 38(12) doi: 10.1002/ptr.8363
|
| 31 |
Liangfei Xu, Jiajia Zhang, Yuhan Xiao, Peipei Jin, Ju Zhang. High-fat diet promotes colorectal tumorigenesis through gut microbiota-mediated metabolic reprogramming and M2 macrophage polarization. Biochemical and Biophysical Research Communications 2026; 794 doi: 10.1016/j.bbrc.2025.153014
|
| 32 |
Huihai Yang, Grace Gar-Lee Yue, Ping-Chung Leung, Chun-Kwok Wong, Ying-Jun Zhang, Clara Bik-San Lau. Human epidermal growth factor receptor 2 as a target of 1,2,3,4,6-penta-O-galloyl-β-d-glucose in colon cancer. Journal of Pharmacy and Pharmacology 2026; 78(2) doi: 10.1093/jpp/rgaf098
|
| 33 |
Jiehao Zhou, Haobo Sun, Hang Zhou, Ying Liu. SPAG4 enhances mitochondrial respiration and aerobic glycolysis in colorectal cancer cells by activating the PI3K/Akt signaling pathway. Journal of Biochemical and Molecular Toxicology 2024; 38(11) doi: 10.1002/jbt.70009
|
| 34 |
Trimethylated Chitosan Nanoparticles for Targeted Treatment of Metastatic Colon Cancer: Mechanisms, Gene Regulation, and Future Positions. ACS Applied Bio Materials 2025; 8(8) doi: 10.1021/acsabm.5c00714
|
| 35 |
Ola J. Hussein, Lubna Therachiyil, Shahd M. Younis, Shaymaa Itani, Hanan H. Abunada, Issam Tout, Cristina Maccalli, Hesham M. Korashy. Comparative proteomic analysis of colorectal cancer stem cells reveals potential biomarkers and altered pathways. Frontiers in Molecular Biosciences 2026; 13 doi: 10.3389/fmolb.2026.1801265
|
| 36 |
Mohammad Taghizadeh-Teymorloei, Vahid Jafarlou, Somaieh Matin, Mortaza Raeisi, Yousef Roosta, Sima Mansouri-Derakhshani, Abbas Ali Hosseinpour Feizi, Abbas Karimi. Clinical implications of Alu-based cell-free DNA and serum onco-piRNA monitoring in colorectal cancer management. Clinical and Translational Oncology 2025; 27(8) doi: 10.1007/s12094-025-03863-8
|
| 37 |
Michael Giarrizzo, Joseph F. LaComb, Hetvi R. Patel, Rohan G. Reddy, John D. Haley, Lee M. Graves, Edwin J. Iwanowicz, Agnieszka B. Bialkowska. TR-107, an Agonist of Caseinolytic Peptidase Proteolytic Subunit, Disrupts Mitochondrial Metabolism and Inhibits the Growth of Human Colorectal Cancer Cells. Molecular Cancer Therapeutics 2024; 23(12) doi: 10.1158/1535-7163.MCT-24-0170
|
| 38 |
Fandi Kong, Yongyan Chen, Dantong Liu, Hongying Gao, Qiaoru Yi, Mengjuan Zhang, Dan Li. Marvelon suppresses MC38 tumor growth and promotes anti-tumor immunity. Molecular Immunology 2025; 182 doi: 10.1016/j.molimm.2025.03.011
|
| 39 |
An Chen, Jiaming He, Qiang Wei, Yuanyuan Wan, Yunying Li, Jing Ma, Jianhua Ran, Jing Li, Dilong Chen. Evodiamine Enhances Chemosensitivity in Colorectal Cancer by Targeting Ribonucleotide Reductase M2. Journal of Biochemical and Molecular Toxicology 2025; 39(11) doi: 10.1002/jbt.70541
|
| 40 |
Kaixu Yang, Mengjie Cui, Typhaine Bejoma, Jiagang Lv, Along Li, Xuejing Peng, Qingjie Zhao. Design, synthesis, and biological evaluation of C-10-esterified dihydroartemisinin-cinnamic acid hybrids as anticancer agents against colorectal cancer. European Journal of Medicinal Chemistry 2026; doi: 10.1016/j.ejmech.2026.119087
|
| 41 |
Zijia Huang, Lingyan Zhou, Hanrui Zheng, Mei Zhan. Cost-effectiveness analysis of fruquintinib in Chinese patients with refractory metastatic colorectal cancer. International Journal of Clinical Pharmacy 2024; 46(4) doi: 10.1007/s11096-024-01721-1
|
| 42 |
Hao Wang, Yi Zhang, Hao Zhang, Hui Cao, Jinning Mao, Xinxin Chen, Liangchi Wang, Nan Zhang, Peng Luo, Ji Xue, Xiaoya Qi, Xiancheng Dong, Guodong Liu, Quan Cheng. Liquid biopsy for human cancer: cancer screening, monitoring, and treatment. MedComm 2024; 5(6) doi: 10.1002/mco2.564
|
| 43 |
Tingshuo Zhao, Yinyi Luo, Yuanjie Sun, Zhigang Wei. Characterizing macrophage diversity in colorectal malignancies through single-cell genomics. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1526668
|
| 44 |
Piotr Kawczak, Tomasz Bączek. Molecular Targeting of EGFR, BRAF, and HER2 Signaling in Colorectal Cancer: Contemporary Advances with Panitumumab, Encorafenib, and Tucatinib. Journal of Clinical Medicine 2026; 15(6) doi: 10.3390/jcm15062387
|
| 45 |
Tamer A. Addissouky. Next Generation of Colorectal Cancer Management: Integrating Omics, Targeted Therapies, and Smart Technologies. Avicenna Journal of Medical Biochemistry 2024; 12(2) doi: 10.34172/ajmb.2530
|
| 46 |
Rui Feng, De-Xin Cheng, Xiao-Chen Chen, Liu Yang, Hao Wu. Application of sintilimab combined with anlotinib hydrochloride in the clinical treatment of microsatellite stable colorectal cancer. World Journal of Gastrointestinal Oncology 2023; 15(11): 1925-1935 doi: 10.4251/wjgo.v15.i11.1925
Abstract(859) |
Core Tip(835) |
Full Article(HTML)(1800)
|
Full Article (PDF)-593K(183)
|
Full Article with Cover (PDF)-883K(170)
|
Full Article (Word)-238K(35)
|
Full Article (XML)-119K(143)
|
Audio-905K(13)
|
Peer-Review Report-227K(139)
|
Answering Reviewers-192K(128)
|
Times Cited (3)
|
Total Visits (3216)
|
Open
|
| 47 |
Ho Kit Mok, Sophie Sneddon, Jianhua Ren, Donald T. T. Yapp, Isabella T. Tai. Tumor cell-intrinsic PD-1 regulates chemotherapy resistance in colorectal cancer cells by activating downstream MAPK signaling. BJC Reports 2025; 3(1) doi: 10.1038/s44276-025-00185-8
|
| 48 |
Hanan R. H. Mohamed, Rawan S. Hekal, Chahd W. H. Fahmy, Shahd O. Elhaggan, Zeina Noure, Nada Ahmed, Ayman Diab, Gehan Safwat. Calcium hydroxide nanoparticles-induced oxidative stress and mitochondrial impairment drive genomic instability and programmed cell death in colorectal cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; doi: 10.1007/s00210-026-05492-6
|